Management of depression: Current trends in primary care

Postgraduate Medicine

Volumn 99, Issue 5, 1996, Pages 179-195

  Kuzel, Russel ^a  

^a Dakota Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; AMPHETAMINE; ANABOLIC AGENT; ANTIDEPRESSANT AGENT; BACLOFEN; BENZODIAZEPINE; CIMETIDINE; CLONIDINE; CYCLOSERINE; DIGITALIS; DISULFIRAM; FLUOXETINE; GLUCOCORTICOID; GUANETHIDINE; LEVODOPA; MAPROTILINE; METOCLOPRAMIDE; NEFAZODONE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

DEPRESSION; DISEASE ASSOCIATION; DYSPHORIA; HUMAN; PRIMARY MEDICAL CARE; REVIEW; RISK FACTOR;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DIAGNOSIS, DIFFERENTIAL; HUMANS; PATIENT COMPLIANCE; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS;

EID: 0029967232     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.1080/00325481.1996.11946126     Document Type: Article

References (28)

1. Depression Guideline Panel. Depression in primary care. Vol 1. Detection and diagnosis. (Clinical practice guideline No. 5) Rockville, Md: Dept of Health and Human Services, 1993; AHCPR publication No. 93-0550
2. Katon W. The epidemiology of depression in medical care. Int J Psychiatry Med 1987; 17(1):93-112
3. Blazer DG, Kessler RC, McGonagle KA, et al. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry 1994;151(7):979-86
4. Greenberg PE, Stiglin LE, Finkelstein SN, et al. The economic burden of depression in 1990. J Clin Psychiatry 1993;54(11):405-18
5. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: Am Psychiatric Assn, 1994
6. Zung WW, Broadhead WE, Roth ME. Prevalence of depressive symptoms in primary care. J Fam Pract 1993;37(4):337-44
7. NIH consensus conference. Diagnosis and treatment of depression in late life. JAMA 1992; 268(8):1018-24
8. Brodaty H. Think of depression: atypical presentations in the elderly. Aust Fam Physician 1993;22(7):1195-203
9. Hamilton M. Distinguishing between anxiety and depressive disorders. In: Last CG, Hersen M, eds. Handbook of anxiety disorders. New York: Pergamon Press, 1988:143-5
10. Horne A, Blazer DG. The prevention of major depression in the elderly. Clin Geriatr Med 1992;8(1):159-72
11. Alexopoulos GS, Abrams RC. Depression in Alzheimer's disease. Psychiatr Clin North Am 1991;14(2):327-40
12. Depression Guideline Panel. Depression in primary care. Vol 2. Treatment of major depression. (Clinical practice guideline No. 5) Rockville, Md: Dept of Health and Human Services, 1993; AHCPR publication No. 93-0551
13. Kupfer DJ. Long-term treatment of depression. J Clin Psychiatry 1991;52(Suppl): 28-34
14. Greden JF. Antidepressant maintenance medications: when to discontinue and how to stop. J Clin Psychiatry 1993;54(Suppl):39-45
15. Keller MB, Lavori PW, Mueller TI, et al. Time to recovery, chronicity, and levels of psychopathology in major depression: a 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry 1992;49(10):809-16
16. McFarland BH. Cost-effectiveness considerations for managed care systems: treating depression in primary care. Am J Med 1994; 97(6A):47-57S
17. Pollock BG. Recent developments in drug metabolism of relevance to psychiatrists. Harvard Rev Psychiatry 1994;2:204-13
18. Serzone product labeling. Princeton, NJ: Bristol-Myers Squibb, 1994
19. Reynolds CF 3rd. Treatment of depression in late life. Am J Med 1994;97(6A):39-46S
20. DeVane CL. Pharmacokinetics of the newer antidepressants: clinical relevance. Am J Med 1994;97(6A):13-23S
21. Effexor prescribing information. In: Physician's desk reference. 49th ed. Montvale, NJ: Medical Economics Data, 1995:2664-8
22. Fontaine R, Ontiveros A, Elie R, et al. A double-blind comparison of nefazodone, imipramine, and placebo in major depression. J Clin Psychiatry 1994;55(6):234-41
23. Rickels K, Schweizer E, Clary C, et al. Nefazodone and imipramine in major depression: a placebo-controlled trial. Br J Psychiatry 1994;164(6):802-5
24. Haria M, Fitton A, McTavish D. Trazodone: a review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders. Drugs Aging 1994;4(4):331-55
25. Wellbutrin prescribing information. Physicians' desk reference. 49th ed. Montvale, NJ: Medical Economics Data, 1995:824-7
26. Workman EA, Short DD. Atypical antidepressants versus imipramine in the treatment of major depression: a meta-analysis. J Clin Psychiatry 1993;54(1):5-12
27. Ray WA, Griffin MR, Schaffner W, et al. Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987;316(7):363-9
28. Hirschfeld RM. Guidelines for the long-term treatment of depression. J Clin Psychiatry 1994;55(Suppl):61-9